[go: up one dir, main page]

JPH0147441B2 - - Google Patents

Info

Publication number
JPH0147441B2
JPH0147441B2 JP54167445A JP16744579A JPH0147441B2 JP H0147441 B2 JPH0147441 B2 JP H0147441B2 JP 54167445 A JP54167445 A JP 54167445A JP 16744579 A JP16744579 A JP 16744579A JP H0147441 B2 JPH0147441 B2 JP H0147441B2
Authority
JP
Japan
Prior art keywords
particles
drug
active ingredient
coated granules
micronized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54167445A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55122712A (en
Inventor
Ii Panosu Donarudo
Koruneiyu Jirubeeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Corp PLC
Original Assignee
Elan Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp PLC filed Critical Elan Corp PLC
Publication of JPS55122712A publication Critical patent/JPS55122712A/ja
Publication of JPH0147441B2 publication Critical patent/JPH0147441B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
JP16744579A 1978-12-22 1979-12-22 Novel medicine state of oral drug and its manufacture Granted JPS55122712A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7836084A FR2444460A1 (fr) 1978-12-22 1978-12-22 Nouvelle forme galenique a usage oral, et son procede de preparation

Publications (2)

Publication Number Publication Date
JPS55122712A JPS55122712A (en) 1980-09-20
JPH0147441B2 true JPH0147441B2 (de) 1989-10-13

Family

ID=9216437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16744579A Granted JPS55122712A (en) 1978-12-22 1979-12-22 Novel medicine state of oral drug and its manufacture

Country Status (3)

Country Link
JP (1) JPS55122712A (de)
BE (1) BE880648A (de)
FR (1) FR2444460A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB785262A (en) * 1955-09-23 1957-10-23 Smith Kline & French Internat Improvements in or relating to hypotensive and sedative preparations
US2809918A (en) * 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
GB1551954A (en) * 1975-05-28 1979-09-05 Hoffmann La Roche Standardization of a physiochemical parameter of a batch of formulation in tabletted form

Also Published As

Publication number Publication date
BE880648A (fr) 1980-06-17
FR2444460A1 (fr) 1980-07-18
FR2444460B1 (de) 1981-07-10
JPS55122712A (en) 1980-09-20

Similar Documents

Publication Publication Date Title
US4609542A (en) New pharmaceutical forms for administration of medicaments by oral route, with programmed release
Nayak et al. Drug delivery: Present, past, and future of medicine
AU743154B2 (en) A pharmaceutical composition having two coating layers
JP2001526212A (ja) 咀嚼分散性錠剤の製造法
JPS63280021A (ja) イブプロフェン除放性錠剤及びその製造方法
AU729437B2 (en) Cefadroxil monohydrate tablet formulation
NO173081B (no) Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen
US20080181946A1 (en) Controlled Release Delivery System For Metformin
CN107595794A (zh) 一种盐酸克林霉素棕榈酸酯颗粒及其制备方法
CN105407875A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
JPH0147441B2 (de)
CN105407876B (zh) 抗结核病的稳定的包含异烟肼颗粒和利福喷汀颗粒的可分散的片剂及其制备方法
CN100548276C (zh) 熔融配制而成的多颗粒口服剂型
US20090149543A1 (en) Solid pharmaceutical compositions comprising lumiracoxib
JP2001139469A (ja) 新しい徐放性薬剤複合体
Singh et al. Dosage forms: non-parenterals
EP1395224A2 (de) Gesicherte orale dosierform
CN117797105A (zh) 一种奥卡西平咀嚼片及其制备方法
WO2017078557A1 (ru) Изготовление таблетки с механизмом повышения терапевтической эффективности лекарственного средства нанодозой аналога
Patel Formulation Development and Optimization of Effervescent Systems for Histamine Antagonists
US20040156844A1 (en) Tamper resistant oral dosage form
JP2002128670A (ja) 錠剤用医薬組成物
HK1092715B (en) Melt-formulated, multi-particulate oral dosage form